Eli Lilly expects to raise at least $1.45bn from Elanco IPO

The US-based group Eli Lilly expects to raise at least $1.45bn by listing 20% of its Elanco division (Animal Health business), that is approximately 63 million shares at a price between $20 and $23 per share. The decision to list Elanco was announced in June, in contrast with rumors about a sale of the business.

(Source: Reuters)